EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets

Yue He iD, Kristina B V Døssing iD, Ane Beth Sloth iD, Xuening He, Maria Rossing, Andreas Kjaer iD

Cancers · 02.03.2023 · 15 (5) · 1557

DOI: 10.3390/cancers15051557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 02.03.2023. Verfasst von Yue He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Resuscitation Council, Danish National Research Foundation, Click-It.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting glioblastoma (GBM) stem-like cells (GSCs) is a common interest in both the laboratory investigation and clinical treatment of GBM. Most of the currently applied GBM stem-like markers lack validation and comparison with common standards regarding their efficiency and feasibility in various targeting methods. Using single-cell RNA sequencing datasets from 37 GBM patients, we obtained a large pool of 2173 GBM stem-like marker candidates. To evaluate and select these candidates quantitatively, we characterized the efficiency of the candidate markers in targeting the GBM stem-like cells by their frequencies and significance of being the stem-like cluster markers. This was followed by further selection based on either their differential expression in GBM stem-like cells compared with normal brain cells or their relative expression level compared with other expressed genes. The cellular location of the translated protein was also considered. Different combinations of selection criteria highlight different markers for different application scenarios. By comparing the commonly used GSCs marker CD133 (PROM1) with markers selected by our method regarding their universality, significance, and abundance, we revealed the limitations of CD133 as a GBM stem-like marker. Overall, we propose BCAN, PTPRZ1, SOX4, etc. for laboratory-based assays with samples free of normal cells. For in vivo targeting applications that require high efficiency in targeting the stem-like subtype, the ability to distinguish GSCs from normal brain cells, and a high expression level, we recommend the intracellular marker TUBB3 and the surface markers PTPRS and GPR56.

Schlagwörter

Stichwörter der Autor:innen

CD133CD15CD24GBM stem-like markersSOX2glioblastoma stem cellsquantitative evaluationsingle-cell RNA sequencing

Autor:innen und Institutionen

  • Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denma…
  • Computational and RNA Biology, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.

ORCID-Profile: Yue He, Kristina B V Døssing, Ane Beth Sloth, Andreas Kjaer

Förderung

  • European Resuscitation Council
  • Danish National Research Foundation
  • Click-It
  • European Union’s Horizon 2020 research and innovation program
  • Lundbeck Foundation, the Novo Nordisk Foundation, the Innovation Fund Denmark, the Neuroendocrine Tumor Research Foundation, the Danish Cancer Society, Arvid N…
  • PERSIMUNE, the Research Council of the Capital Region of Denmark, the Danish Health Authority, the John and Birthe Meyer Foundation and Research Council for In…

Zitieren

APA

He, Y., Døssing, K. B. V., Sloth, A. B., He, X., Rossing, M., & Kjaer, A. (2023). Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets. Cancers, 15(5), 1557. https://doi.org/10.3390/cancers15051557

Vancouver

He Y, Døssing KBV, Sloth AB, He X, Rossing M, Kjaer A. Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets. Cancers. 2023;15(5):1557. doi:10.3390/cancers15051557

BibTeX
@article{He2023,
  author = {He, Yue and Døssing, Kristina B V and Sloth, Ane Beth and He, Xuening and Rossing, Maria and Kjaer, Andreas},
  title = {Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1557},
  doi = {10.3390/cancers15051557}
}
Kostenlos starten →